BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14100889)

  • 1. EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.
    HOWARD RP; ALAUPOVIC P; BRUSCO OJ; FURMAN RH
    J Atheroscler Res; 1963; 3():482-99. PubMed ID: 14100889
    [No Abstract]   [Full Text] [Related]  

  • 2. THE RESPONSE OF HYPERLIPOPROTEINEMIAS TO ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH
    J Atheroscler Res; 1963; 3():445-53. PubMed ID: 14100885
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECT OF ATROMID ON PLASMA LIPIDS AND LIPROPROTEINS IN SUBJECTS WITH HYPERLIPOPROTEINEMIA. (A PRELIMINARY REPORT).
    CARLSON LA; HOEGSTEDT B; OROE L
    J Atheroscler Res; 1963; 3():467-74. PubMed ID: 14100887
    [No Abstract]   [Full Text] [Related]  

  • 4. ACTION OF ATROMID ON SERUM LIPIDS AND ON BETA-LIPOPROTEIN LIPIDS AND PROTEIN.
    CRAMER K
    J Atheroscler Res; 1963; 3():500-8. PubMed ID: 14100890
    [No Abstract]   [Full Text] [Related]  

  • 5. THE TREATMENT OF XANTHOMATOSIS WITH "ATROMID".
    MISHKEL MA
    Med J Aust; 1964 Nov; 2():828-33. PubMed ID: 14226559
    [No Abstract]   [Full Text] [Related]  

  • 6. REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE.
    HELLMAN L; ZUMOFF B; KESSLER G; KARA E; RUBIN IL; ROSENFELD RS
    J Atheroscler Res; 1963; 3():454-66. PubMed ID: 14100886
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.
    OLIVER MF; ROBERTS SD; HAYES D; PANTRIDGE JF; SUZMAN MM; BERSOHN I
    Lancet; 1963 Jan; 1(7273):143-4. PubMed ID: 13940003
    [No Abstract]   [Full Text] [Related]  

  • 8. BETA-LIPOPROTEIN, LIPOPROTEIN LIPASE AND ATROMID.
    HOOD B; BEDDING P; CARLANDER B
    J Atheroscler Res; 1963; 3():509-17. PubMed ID: 14100891
    [No Abstract]   [Full Text] [Related]  

  • 9. THE EFFECTS OF ATROMID ON THE ALPHA-BETA-LIPOPROTEIN RATIO IN CORONARY DISEASE.
    KERNOHAN RJ; NEELY RA
    J Atheroscler Res; 1963; 3():518-24. PubMed ID: 14100892
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON LOW-DENSITY LIPOPROTEIN TURNOVER IN RELATION TO ATROMID THERAPY.
    WALTON KW; SCOTT PJ; VERRIERJONES J; FLETCHER RF; WHITEHEAD T
    J Atheroscler Res; 1963; 3():396-414. PubMed ID: 14100881
    [No Abstract]   [Full Text] [Related]  

  • 11. THE EFFECT OF ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE ON THE EXCRETION OF URIC ACID. A PRELIMINARY REPORT.
    TREVAKS G; LOVELL RR
    J Atheroscler Res; 1963; 3():725. PubMed ID: 14100918
    [No Abstract]   [Full Text] [Related]  

  • 12. MULTICENTRE TRIAL IN THE UNITED KINGDOM AND IRELAND OF A MIXTURE OF ETHYL CHLOROPHENOXYISOBUTYRATE AND ANDROSTERONE (ATROMID). A PRELIMINARY REPORT.
    GREEN KG; INMAN WH; THORP JM
    J Atheroscler Res; 1963; 3():593-616. PubMed ID: 14104298
    [No Abstract]   [Full Text] [Related]  

  • 13. SERUM LIPID AND LIPOPROTEIN CHANGES AFTER TREATMENT WITH ATROMID IN PATIENTS WITH ATHEROSCLEROSIS, ESSENTIAL HYPERLIPAEMIA AND FAMILIAL HYPERCHOLESTEROLAEMIA.
    FASOLI A; CESANA A
    J Atheroscler Res; 1963; 3():475-81. PubMed ID: 14100888
    [No Abstract]   [Full Text] [Related]  

  • 14. A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.
    PEAK HJ; MITCHELL AS; JOSE AD
    Med J Aust; 1965 Jul; 2(5):192-4. PubMed ID: 14348329
    [No Abstract]   [Full Text] [Related]  

  • 15. ATROMID AND ANTICOAGULANT THERAPY.
    WILLIAMS GE; MEYNELL MJ; GADDIE R
    J Atheroscler Res; 1963; 3():658-70. PubMed ID: 14100910
    [No Abstract]   [Full Text] [Related]  

  • 16. OBSERVATIONS UPON THE METABOLIC EFFECTS OF ATROMID.
    WYNN V
    J Atheroscler Res; 1963; 3():361-79. PubMed ID: 14100879
    [No Abstract]   [Full Text] [Related]  

  • 17. [EFFECT OF DEHYDROEPIANDROSTERONE AND ATROMID ON SERUM LIPIDS IN PATIENTS WITH HYPERCHOLESTEREMIA OR HYPERTRIGLYCERIDEMIA].
    FELT V; STARKA L; BEDNAR J
    Cas Lek Cesk; 1965 Feb; 104():186-9. PubMed ID: 14310921
    [No Abstract]   [Full Text] [Related]  

  • 18. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    BEST MM; DUNCAN CH
    J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
    [No Abstract]   [Full Text] [Related]  

  • 19. THE EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE ON THE BINDING BETWEEN TRIIODOTHYRONINE AND PROTEIN.
    MOGENSEN EF
    J Atheroscler Res; 1963; 3():415-7. PubMed ID: 14100882
    [No Abstract]   [Full Text] [Related]  

  • 20. FURTHER OBSERVATIONS ON THE EFFECTS OF ATROMID AND OF ETHYL CHLOROPHENOXYISOBUTYRATE ON SERUM LIPID LEVELS.
    OLIVER MF
    J Atheroscler Res; 1963; 3():427-44. PubMed ID: 14100884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.